BECTON DICKINSON & CO — Director's Dealing 2025

Dec 17, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2025-12-17

Reporting Person: Garrison Michael David (EVP & Pres Med.Essntl&BioPharm)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-17	Common Stock	S	629	$196.03	Disposed	13105	Direct